Search results
Results from the WOW.Com Content Network
Selman Abraham Waksman (July 22, 1888 – August 16, 1973) was a Jewish American inventor, Nobel Prize laureate, biochemist and microbiologist whose research into the decomposition of organisms that live in soil enabled the discovery of streptomycin and several other antibiotics.
Elizabeth Bugie Gregory (October 5, 1920 – April 10, 2001) was an American biochemist who co-discovered Streptomycin, the first antibiotic against Mycobacterium tuberculosis in Selman Waksman laboratory at Rutgers University. [1]
In the afternoon of 19 October, Schatz noticed that the tuberculosis bacteria were killed by his actinomycete extract, which he gave the name "streptomycin" [6] following the scientific name of the source and the earlier antibiotic streptothricin discovered by Waksman and H. Boyd Woodruff in 1942. [15]
Streptomycin is an antibiotic medication used to treat a number of bacterial infections, [3] including tuberculosis, Mycobacterium avium complex, endocarditis, brucellosis, Burkholderia infection, plague, tularemia, and rat bite fever. [3] For active tuberculosis it is often given together with isoniazid, rifampicin, and pyrazinamide. [4]
The name was changed in 1948 by Waksman and Henrici to Streptomyces griseus. The interest in these strains stems from their ability to produce streptomycin, a compound which demonstrated significant bactericidal activity against organisms such as Yersinia pestis (the causative agent of plague) and Mycobacterium tuberculosis (the causative agent ...
Streptomyces antibioticus was discovered by Selman Waksman and H. Boyd Woodruff, who named the bacterium Actinomyces antibioticus. [2] In their 1941 publication, Waksman and Woodruff describe their use of the "bacterial-agar plate method", in which they mixed a suspension of E. coli with washed agar containing 1.5% NaCl and 0.5% K 3 PO 4. [2]
The history of the tetracyclines involves the collective contributions of thousands of dedicated researchers, scientists, clinicians, and business executives. Tetracyclines were discovered in the 1940s, first reported in scientific literature in 1948, and exhibited activity against a wide range of microorganisms.
Sequence alignments of actinomycetotal genomes have led to the identification of three conserved signature indels which are unique to the order Streptomycetales. The enzyme PBGD contains a four-amino-acid insertion which is present in all Streptomyces species and Kitasatospora setae, but not any other Actinomycetota.